Antifibrotic Agents

Name
Antifibrotic Agents
Accession Number
DBCAT003767
Description

Not Available

Drugs
DrugDrug Description
PirfenidoneAn agent used for the treatment of idiopathic pulmonary fibrosis (IPF).
NintedanibA triple angiokinase inhibitor indicated for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and in combination with docetaxel for non-small cell lung cancer.
Drugs & Drug Targets
DrugTargetType
PirfenidoneCytochrome P450 1A2enzyme
PirfenidoneCytochrome P450 2C9enzyme
PirfenidoneCytochrome P450 2C19enzyme
PirfenidoneCytochrome P450 2D6enzyme
PirfenidoneCytochrome P450 2E1enzyme
PirfenidoneSerum albumincarrier
PirfenidoneCytochrome P450 3A4enzyme
PirfenidoneP-glycoprotein 1transporter
NintedanibVascular endothelial growth factor receptor 1target
NintedanibVascular endothelial growth factor receptor 2target
NintedanibVascular endothelial growth factor receptor 3target
NintedanibPlatelet-derived growth factor receptor alphatarget
NintedanibPlatelet-derived growth factor receptor betatarget
NintedanibFibroblast growth factor receptor 1target
NintedanibFibroblast growth factor receptor 2target
NintedanibFibroblast growth factor receptor 3target
NintedanibReceptor-type tyrosine-protein kinase FLT3target
NintedanibTyrosine-protein kinase Lcktarget
NintedanibTyrosine-protein kinase Lyntarget
NintedanibProto-oncogene tyrosine-protein kinase Srctarget
NintedanibP-glycoprotein 1transporter
NintedanibCytochrome P450 3A4enzyme
NintedanibSolute carrier family 22 member 1transporter
NintedanibSerum albumincarrier
NintedanibUDP-glucuronosyltransferase 1-1enzyme
NintedanibUDP-glucuronosyltransferase 1-7enzyme
NintedanibUDP-glucuronosyltransferase 1-8enzyme
NintedanibUDP-glucuronosyltransferase 1-10enzyme
NintedanibATP-binding cassette sub-family G member 2transporter